Mooren H W, Kramps J A, Franken C, Meijer C J, Dijkman J A
Thorax. 1983 Mar;38(3):180-3. doi: 10.1136/thx.38.3.180.
The localisation of a low-molecular-weight bronchial protease inhibitor (LMI) in human peripheral lung tissue was studied by an immunohistochemical method. This inhibitor was found exclusively in a part of the non-ciliated cell population of the bronchiolar epithelium. An inverse relationship was observed between the number of LMI-positive non-ciliated cells per millimetre of basement membrane and the bronchiolar diameter. These findings may have a bearing on the protease-antiprotease theory of the development of pulmonary emphysema, LMI possibly playing a part in the protection of peripheral lung tissue against proteolytic destruction by enzymes liberated from granulocytes or migrating alveolar macrophages.
采用免疫组化方法研究了低分子量支气管蛋白酶抑制剂(LMI)在人外周肺组织中的定位。该抑制剂仅在细支气管上皮的部分无纤毛细胞群体中发现。每毫米基底膜上LMI阳性无纤毛细胞的数量与细支气管直径之间呈负相关。这些发现可能与肺气肿发生发展的蛋白酶-抗蛋白酶理论有关,LMI可能在保护外周肺组织免受粒细胞或迁移的肺泡巨噬细胞释放的酶的蛋白水解破坏中发挥作用。